Searched for
CONCORD BIOTECH SHARE NEWS
US Stocks: Nasdaq, S&P end lower as tech megacap declines outweigh upbeat chip outlookIndian markets saw a mixed close on Thursday. While the Nasdaq and S&P dipped due to Big Tech's AI spending concerns, the Dow edged higher....- Centre eyes medical tourism boost with funding support for hospitalsIndia is gearing up to become a global medical tourism powerhouse with a new government scheme. Funding will boost hospitals, colleges, and...
- Life performs better in heat, but what happens next surprised scientistsGlobal warming climate change study: A groundbreaking analysis of over 30,000 experiments reveals a universal pattern in how life responds ...
- China begins to snap at America's heels in a tightening tech raceChina’s latest supercomputer ranking has renewed debate over global technology leadership, but current evidence shows the United States sti...
- Nancy Guthrie case mystery deepens as investigators focus on anonymous tipster linked to ransom messages-here's what you need to knowA mysterious anonymous tipster, believed by investigators to be a woman despite using male aliases, has provided new leads in the Nancy Gut...
- US Stocks | Nasdaq futures surge 2% as chip outlook calms AI jitters; inflation data awaitedIndian markets are set for a positive opening as US futures surged, led by a 2.24% jump in the Nasdaq. Memory chip giants Micron and Qualco...
- SK Hynix surges 12% as US listing plan boosts valuation hopesSK Hynix shares surged as much as 12% after the memory chipmaker unveiled plans for a $29 billion US listing, boosting hopes of higher valu...
- Ben Lamm and Colossal Biosciences: The billionaire tech founder behind the $10 billion plan to bring back extinct animalsTech entrepreneur Ben Lamm is spearheading Colossal Biosciences, a company aiming to bring back extinct species like the woolly mammoth thr...
- Vedanta shares fall 6% after Rs 2,149 crore block deal; promoter Twin Star likely sellerVedanta's stock experienced a significant dip, dropping up to 6% from its intraday peak of Rs 287. This decline followed media speculation ...
- US stocks: S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on IranUS market saw a mixed close as the S&P 500 and Nasdaq dipped, primarily due to tech giants like Alphabet facing investor scrutiny over AI s...
- When frontier AI can be switched off: India's sovereignty challengeIndia must not depend on foreign AI models, as US export controls demonstrate potential access denial. Past reliance on external tech, like...
- US stocks today: S&P 500, Dow tick higher as investors weigh Mideast negotiationsWall Street's major indexes opened little changed on Monday as investors returned from the long holiday weekend and awaited clarity on US-I...
- Micron Technology stock price jumps on Monday, shares up nearly 300 per cent for 2026U.S. Stock Market today: Micron Technology shares moved higher in premarket trading on Monday. AI-driven optimism has supported Wall Stree...
- Rs 35,000 crore Jio IPO may not be a jackpot for Reliance investors. Here's whyReliance has kicked off the IPO process for Jio Platforms with a proposed Rs 35,000–40,000 crore issue, expected to be India's biggest IPO....
- Russia eyes ports, biotech for rupee surplus investments in IndiaRussia is eyeing India's burgeoning infrastructure, particularly its ports, for investments using accumulated rupee funds. Discussions are ...
- Mutual funds added these 4 new stocks to their portfolios in May. Check detailsMutual funds introduced four new stocks into their portfolios in May, according to Prime Database disclosures. Afcom Holdings saw the highe...
- Karnataka explores biotech financing framework, AI-led innovation to support sector growthKarnataka is developing a dedicated support framework for its biotechnology sector, encompassing funding, mentoring, and regulatory guidanc...
- Two Trades for Today: A maker of forged components for a 7.7% gain, a mid-cap pharma stock for a 6% upmoveOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...
- Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspensionConcord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...
Load More
